The Library
This is where we keep the studies that back up what we do. Peer-reviewed science on adaptogens, open access, with a plain-language summary and the original text one click away. No veils, no smoke. Read it yourself and draw your own conclusions.
Frontiers in Neuroscience · 2013
This study mapped which genes switch on and off when human brain cells meet ADAPT-232 (rhodiola, schisandra, and eleuthero) versus each ingredient on its own. Combining two or more, the blend lit up genes that no single ingredient touched alone (synergy) and quieted others (antagonism). It behaved like a new compound, with a fingerprint of its own.
Medicinal Research Reviews · 2021
A sweeping review follows adaptogens from Chinese medicine, Ayurveda, and Russian pharmacology all the way to modern systems biology. The key point is the dose. They act on a biphasic curve: a modest, steady amount works like a light rehearsal of stress that trains the body's resistance. Push the dose too high and the effect flips. More is not better.
Pharmaceuticals · 2022
For a century, drug design chased the magic bullet: one molecule, one target, one effect. This review explains why that model does not fit adaptogens. Drawing on gene-expression studies, it shows they touch many targets and many pathways at once. Instead of hitting a single receptor, they send small adjustment signals across the stress, defense, and hormone systems so the whole network settles into balance.
Pharmaceuticals · 2010
This review brings together animal studies, isolated-cell work, and human trials to see what adaptogens do inside the brain. Instead of forcing the nervous system into overdrive like caffeine, they seem to help the stress system hold its balance. In the trials, what stood out most was greater tolerance for mental fatigue and more sustained attention under pressure.
Frontiers in Neuroscience · 2012
Scientists went looking for the first domino adaptogens push when they calm your stress response. In human brain support cells, the ADAPT-232 blend made them produce and release two things: neuropeptide Y, a natural calming molecule, and Hsp72, a repair protein. When they silenced the neuropeptide Y gene, the protection collapsed. There was the trigger.
This study was published under a non-commercial license, so we cannot host it here. We leave you our summary and the link to the original publication.
Pharmaceuticals · 2025
This review focuses on long-lasting brain fatigue, that heavy tiredness that can linger after an infection, chronic inflammation, or sustained overload. The authors walk through the biology: scrambled brain chemistry, disrupted energy, and a stress system knocked out of balance. Their argument is that adaptogens may support the slow rebuild, and for the first time they suggest these plants might even help new brain tissue grow.
Frontiers in Pharmacology · 2023
This opinion piece steps into the old fight between two camps: those who want a single pure compound, easy to standardize, and those who defend the whole plant because it hits many targets at once. The author's verdict is a truce: both have real strengths. But he adds an honest warning. Synergy cannot be taken for granted from tradition or from a computer model. It has to be proven in the lab.
